Changdev G. Gadhe
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Mice deficient in TWIK-1 are more susceptible to kainic acid-induced seizures.
Journal: iScience
Published: May 07, 2024
Development of 18F-Labeled PET Tracer Candidates for Imaging of the Abelson Non-receptor Tyrosine Kinase in Parkinson's Disease.
Journal: Journal of medicinal chemistry
Published: September 15, 2023
A novel small molecule, CU05-1189, targeting the pleckstrin homology domain of PDK1 suppresses VEGF-mediated angiogenesis and tumor growth by blocking the Akt signaling pathway.
Journal: Frontiers in pharmacology
Published: August 10, 2023
Glutamate Permeability of Chicken Best1.
Journal: Experimental neurobiology
Published: October 16, 2022
Correction to "A Novel, Selective c-Abl Inhibitor, Compound 5, Prevents Neurodegeneration in Parkinson's Disease".
Journal: Journal of medicinal chemistry
Published: December 02, 2021
A Novel, Selective c-Abl Inhibitor, Compound 5, Prevents Neurodegeneration in Parkinson's Disease.
Journal: Journal of medicinal chemistry
Published: September 29, 2021
PyrPeg, a Blood-Brain-Barrier-Penetrating Two-Photon Imaging Probe, Selectively Detects Neuritic Plaques, Not Tau Aggregates.
Journal: ACS chemical neuroscience
Published: May 19, 2020
3-Carene, a Phytoncide from Pine Tree Has a Sleep-enhancing Effect by Targeting the GABAA-benzodiazepine Receptors.
Journal: Experimental neurobiology
Published: October 18, 2019
Structure-activity relationships of fluorene compounds inhibiting HCV variants.
Journal: Antiviral research
Published: October 15, 2019
Investigation of Molecular Details of Keap1-Nrf2 Inhibitors Using Molecular Dynamics and Umbrella Sampling Techniques.
Journal: Molecules (Basel, Switzerland)
Published: September 07, 2019
Development of an Aryloxazole Derivative as a Brain-Permeable Anti-Glioblastoma Agent.
Journal: Pharmaceutics
Published: September 02, 2019
Development of Oxadiazole-Based ODZ10117 as a Small-Molecule Inhibitor of STAT3 for Targeted Cancer Therapy.
Journal: Journal of clinical medicine
Published: August 27, 2019
Last Updated: 09/26/2026